- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Evaluation
Program
Speakers
Sponsor list
Accreditation

IMCAS Asia 2025
Program

Contributed Talks: Hair restoration

Room: Room 5 - Level 2
Date: Sunday 8 June 2025 at 15:00 to 16:00
Format: CONTRIBUTED TALKS > session made up of abstract submissions that were carefully reviewed and selected by the Scientific Board

Chairs

Dr Suparuj LUEANGARUN

Internal medicine

Thailand

Dr Chuchai TANGLERTSAMPAN

Dermatologist

Thailand

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
15:00	Dr Rafael FORTUS	Gender-affirming hair restoration	View	147178
15:12	Dr Fatemeh MOEINEDDIN	Efficacy of microneedling with exosome treatment of androgenetic alopecia: A clinical study on 72 patients	View	147179
15:24	Dr Arman MOHAMMADI	Novel dual-modality therapy in androgenetic alopecia: Randomized parallel-group trial of Er:Glass 1540 nm plus microneedling VS microneedling alone	View	147180
15:36	Dr Christopher Toshihiro WIRYA	Managing androgenetic alopecia in aesthetic practice: Practical, evidence-based treatment strategies	View	150287
15:48		Q&A		147181

Go to previous session

Go to next session

Recommended sessions

Alopecia (hair loss)

Lasers

Hair transplants (FUE, FUT)

Home use devices

Exosomes

Dr Rafael FORTUS

Philippines

Other author(s) :

Gender-affirming hair restoration

Objectives: 1. Develop a holistic and comprehensive approach to gender-affirming hair transplantation.
2. Identify the common gender-affirming features of hairline, eyebrow and beard transplantation.
3. Understand the key surgical, medical and structural factors that mitigate risk and improve patient satisfaction.

Introduction: Hairlines and hairstyles have long defined masculinity and femininity, hair transplantation is an effective and permanent solution to affirming a person’s gender identity. A careful history is required with open-questioned approach to gender identity and goals. There are surgical, medical and structural factors that should be managed to mitigate risk and improve aesthetic outcomes.

Materials / method: For transgender women, hairline designs should be rounder and close the temporal angles, with a soft ‘feathered’ edge. For transgender men, hair transplants can create thicker eyebrows and beards can be designed for facial masculinization.

Surgical sequencing is important; recent breast augmentation of hyoid shaving may preclude prone positioning for hair transplantation. Exogenous testosterone may cause hairline recession in transgender men, a typical male feature, though some will want this corrected while maintaining a masculine hairline.

Results: The success of gender affirming hair transplants is underpinned by proper technique- extractions that do to leave the donor zone scant, hair graft processing to ensure high percentage of graft survival, and implantation that follows direction, desired densities, and design. Post operative care between the genders is similar, though Finasteride should be reserved for biological males.

The presentation includes real-case examples and photos of hairline feminization, eyebrow implantation for both males and females and beard design variability.

Conclusion: Some patients do not fall in the binary gender classifications, so understanding the patient’s goals is more important than classifying their gender. Therefore ‘feminization of the hairline’ may not always be the appropriate term; some patients may prefer a more mathematical or purely aesthetic approach. Transitioning between genders is a non-linear process. Proper surgical planning and medical support can improve outcomes and patient satisfaction.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Fatemeh MOEINEDDIN

Dermatologist

United Arab Emirates

Other author(s) :

Efficacy of microneedling with exosome treatment of androgenetic alopecia: A clinical study on 72 patients

Objectives: This study investigates the efficacy and safety of microneedling combined with a single administration of 1 cc exosomes in patients with AGA.

Introduction: Androgenetic alopecia (AGA) is a prevalent condition characterized by progressive hair thinning. Emerging regenerative therapies, including microneedling and exosome-based treatments, have shown promise in stimulating hair regrowth. This study investigates the efficacy and safety of microneedling combined with a single administration of 1 cc exosomes in patients with AGA.

Materials / method: Seventy-two patients (48 males, 24 females) with AGA received three sessions of microneedling at four-week intervals. A single dose of 1 cc exosomes was applied topically during the first session. Hair density and thickness were evaluated using digital trichoscopy at baseline and 12 weeks post-treatment. Global photographic assessment and patient satisfaction scores were recorded. Adverse events were monitored.

Results: Significant improvements in hair density and thickness were observed at 12 weeks compared to baseline (p < 0.05). Global photographic evaluations indicated moderate to marked improvement in 73% of patients. Patient-reported satisfaction was high, with 80% noting visible hair regrowth. Side effects were minimal, including transient erythema and mild discomfort . No severe adverse reactions were reported.

Conclusion: A single application of 1 cc exosomes combined with three microneedling sessions is a promising and well-tolerated approach for treating AGA. Further studies with extended follow-ups are recommended to determine long-term efficacy and optimize treatment protocols.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Arman MOHAMMADI

Iran

Other author(s) : Ahmad Nazari MD

Novel dual-modality therapy in androgenetic alopecia: Randomized parallel-group trial of Er:Glass 1540 nm plus microneedling VS microneedling alone

Objectives: This study compares the therapeutic outcomes of combining a 1540 nm erbium:glass fractional laser with microneedling versus microneedling alone for moderate androgenetic alopecia. The primary aim is to determine whether fractional photothermal stimulation augments hair density, follicle diameter, and overall scalp coverage beyond what microneedling alone can achieve, while maintaining an acceptable safety profile in both male and female participants.

Introduction: Androgenetic alopecia is a prevalent, progressive condition affecting men and women, characterized by hormonal sensitivity and gradual follicular miniaturization. Recent evidence highlights the regenerative potential of controlled dermal injury, via microneedling or non-ablative laser, in stimulating hair follicle stem cells. However, data remain scarce regarding the synergistic effect of combining these techniques to maximize hair regrowth and improve scalp coverage in moderate disease severity.

Materials / method: A randomized, parallel-group trial enrolled 26 adults with moderate androgenetic alopecia, divided equally into two arms. Group A received three monthly sessions of a 1540 nm erbium:glass fractional laser applied to the scalp immediately followed by microneedling; Group B underwent identical microneedling but without laser. Digital trichoscopy assessed hair density (hairs/cm²) and shaft thickness at baseline and two months post-final session. Safety outcomes were recorded at each visit.

Results: Compared to baseline, Group A showed a significantly greater rise in hair density (mean +18.2%±3.4) than Group B (mean +9.4%±2.8; p<0.01). Follicle diameter likewise increased more in Group A (+16.1%±2.7) versus Group B (+8.5%±2.3; p<0.05). Photographic and trichoscopic evaluations revealed notably improved scalp coverage in the combination group. Mild erythema was observed in both cohorts, resolving within 24–48 hours, with no serious adverse events reported.

Conclusion: Adding a 1540 nm erbium:glass fractional laser to microneedling confers superior hair regrowth outcomes compared to microneedling alone in moderate androgenetic alopecia. Enhanced follicular stimulation appears to result from synergistic dermal remodeling and localized growth factor release. This minimally invasive combination was well tolerated, suggesting its promise as a next-level approach. Further research with larger cohorts and extended follow-up is warranted to validate and optimize these findings.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Christopher Toshihiro WIRYA

Dermatologist

Indonesia

Other author(s) :

Managing androgenetic alopecia in aesthetic practice: Practical, evidence-based treatment strategies

Objectives: This session aims to simplify the management of androgenetic alopecia in aesthetic practice. learn to identify common patterns of hair loss, choose safe and effective treatments including low-dose Finasteride, combine therapies like PRP and microneedling, structure 3–6 month treatment plans, and improve patient communication to boost adherence and satisfaction.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Q&A

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress
IMCAS Americas
IMCAS Asia

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Asia 2025 Program

Contributed Talks: Hair restoration

Chairs

Lectures of the session

Recommended sessions

IMCAS Asia 2025
Program